Cenobamate guideline (1145)

Cenobamate is a novel antiseizure medication for the treatment of focal onset seizures in adult patients. Studies done in paediatric cohorts demonstrate similar efficacy rates and safety profiles on par with adult studies. There is evidence that Cenobamate can be used as an effective, safe, and tolerable adjunctive medication despite being currently unlicensed in children. This guidance is intended to support good practice around the prescription of Cenobamate and facilitate the audit of therapeutic trials.

NOTE: this guideline is hosted on the NHSGGC Paediatrics Guidelines website. Clicking on the link below will open the guideline in a new window.

Resources

Use the button below to access this item.

Access this resource